University of Colorado Cancer Center team uses liquid biopsy to predict multiple myeloma drug resistance and sensitivity.
28-May-2020 12:10 PM EDT Add to Favorites
University of Colorado Cancer Center study of early-phase clinical trials finds variations in reporting of drug side effects, potentially obscuring safety.
28-Apr-2020 2:30 PM EDT Add to Favorites
Series of Rare Right-Colon Twists Highlights Need for Doctor Vigilance with New, Targeted Anti-Cancer Drugs
Study: with smaller clinical trials, it may be up to doctors to notice rare drug side effects
22-Apr-2020 10:05 AM EDT Add to Favorites
Live, single-cell imaging shows that cells continuously integrate the influence of growth factors, not just during G1 phase of cell cycle, as previously thought.
2-Apr-2020 3:05 PM EDT Add to Favorites
University of Colorado Cancer Center group shows CPT1A may be necessary for ovarian cancer spread, chemo-resistance. Moves toward clinical trial of CPT1A inhibitor, etomoxir, against chemo-resistant ovarian cancer.
26-Mar-2020 11:55 AM EDT Add to Favorites
Chemotherapy has been so unsuccessful against DIPG that researchers have questioned whether chemotherapy drugs are even able to reach the cancer. University of Colorado Cancer Center study shows, "... medicine does reach DIPG tissue in good...
25-Mar-2020 4:50 PM EDT Add to Favorites
“Two independent sources with the same scientific finding make you think it’s true,” says Jean Mulcahy-Levy, MD, investigator at CU Cancer Center and associate professor in the CU School of Medicine Department of Pediatrics.
19-Mar-2020 4:35 PM EDT Add to Favorites
Could medicines that activate the immune system protect against COVID-19 infection?
19-Mar-2020 12:05 PM EDT Add to Favorites
See All News
Benjamin Brewer, PsyD, is a University of Colorado Cancer Center investigator and health psychologist at the UCHealth University of Colorado Hospital Bone Marrow Transplant Program. Here CU Cancer Center talks with Dr. Brewer about his patients’...
6-Apr-2020 12:05 PM EDT
27-Jul-2015 11:05 AM EDT
An education session presented today at the American Society for Clinical Oncology (ASCO) Annual Meeting 2014 details the challenges of collaboration between oncologists and pathologists in the context of molecular testing patient tumor samples.
30-May-2014 4:00 PM EDT